Owlet Inc (OWLT)

$4.16

+0.18

(+4.52%)▲

Market is closed - opens 7 PM, 29 Apr 2024

Insights on Owlet Inc

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 9.18M → 21.0M (in $), with an average increase of 56.3% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 4 quarters, -12.55M → -6.9M (in $), with an average increase of 23.6% per quarter

  • Vs HQY

    In the last 1 year, Healthequity Inc has given 46.8% return, outperforming this stock by 64.1%

  • Vs HQY

    In the last 3 years, Healthequity Inc has given 3.6% return, outperforming this stock by 63.5%

Performance

  • $4.01
    $4.19
    $4.16
    downward going graph

    3.61%

    Downside

    Day's Volatility :4.3%

    Upside

    0.72%

    downward going graph
  • $2.52
    $7.50
    $4.16
    downward going graph

    39.42%

    Downside

    52 Weeks Volatility :66.4%

    Upside

    44.53%

    downward going graph

Returns

PeriodOwlet IncSector (Health Care)Index (Russel 2000)
3 Months
-33.44%
0.5%
0.0%
6 Months
-1.73%
11.7%
0.0%
1 Year
-17.26%
6.2%
2.2%
3 Years
-59.92%
13.5%
-23.0%

Highlights

Market Capitalization
35.7M
Book Value
- $4.27
Earnings Per Share (EPS)
-4.53
Wall Street Target Price
15.0
Profit Margin
-60.92%
Operating Margin TTM
-14.67%
Return On Assets TTM
-35.01%
Return On Equity TTM
-901.15%
Revenue TTM
54.0M
Revenue Per Share TTM
6.53
Quarterly Revenue Growth YOY
75.7%
Gross Profit TTM
23.3M
EBITDA
-27.8M
Diluted Eps TTM
-4.53
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.18
EPS Estimate Current Quarter
-0.04
EPS Estimate Next Quarter
-0.03

Analyst Recommendation

Buy
    85%Buy
    14%Hold
    0
    0%Sell
Based on 7 Wall street analysts offering stock ratings for Owlet Inc(by analysts ranked 0 to 5 stars)
Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
2
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 260.58%

Current $4.16
Target $15.00

Company Financials

FY19Y/Y Change
Revenue
49.8M
-
Net Income
-17.9M
-
Net Profit Margin
-35.84%
-
FY20Y/Y Change
Revenue
75.4M
↑ 51.41%
Net Income
-10.5M
↓ 41.06%
Net Profit Margin
-13.95%
↑ 21.89%
FY21Y/Y Change
Revenue
75.8M
↑ 0.53%
Net Income
-98.2M
↑ 833.06%
Net Profit Margin
-129.51%
↓ 115.56%
FY22Y/Y Change
Revenue
69.2M
↓ 8.71%
Net Income
-79.3M
↓ 19.23%
Net Profit Margin
-114.59%
↑ 14.92%
FY23Y/Y Change
Revenue
54.0M
↓ 21.95%
Net Income
-32.9M
↓ 58.51%
Net Profit Margin
-60.92%
↑ 53.67%
Q3 FY22Q/Q Change
Revenue
17.4M
↓ 5.14%
Net Income
-19.4M
↑ 65.12%
Net Profit Margin
-111.54%
↓ 47.46%
Q4 FY22Q/Q Change
Revenue
12.0
↓ 100.0%
Net Income
-19.0
↓ 100.0%
Net Profit Margin
-162.5%
↓ 50.96%
Q1 FY23Q/Q Change
Revenue
10.7M
↑ 8.916656667E7%
Net Income
-12.6M
↑ 6.437425897E7%
Net Profit Margin
-117.32%
↑ 45.18%
Q2 FY23Q/Q Change
Revenue
13.1M
↑ 22.32%
Net Income
-8.5M
↓ 32.55%
Net Profit Margin
-64.69%
↑ 52.63%
Q3 FY23Q/Q Change
Revenue
9.2M
↓ 29.84%
Net Income
-7.0M
↓ 17.8%
Net Profit Margin
-75.8%
↓ 11.11%
Q4 FY23Q/Q Change
Revenue
21.0M
↑ 128.71%
Net Income
-6.9M
↓ 0.86%
Net Profit Margin
-32.86%
↑ 42.94%
FY19Y/Y Change
Total Assets
28.2M
-
Total Liabilities
38.9M
-
FY20Y/Y Change
Total Assets
40.1M
↑ 42.26%
Total Liabilities
60.9M
↑ 56.76%
FY21Y/Y Change
Total Assets
140.0M
↑ 248.97%
Total Liabilities
84.8M
↑ 39.16%
FY22Y/Y Change
Total Assets
58.1M
↓ 58.5%
Total Liabilities
68.7M
↓ 18.99%
FY23Y/Y Change
Total Assets
44.1M
↓ 24.06%
Total Liabilities
73.8M
↑ 7.42%
Q3 FY22Q/Q Change
Total Assets
80.7M
↓ 20.82%
Total Liabilities
76.3M
↓ 5.15%
Q4 FY22Q/Q Change
Total Assets
58.1K
↓ 99.93%
Total Liabilities
68.7K
↓ 99.91%
Q1 FY23Q/Q Change
Total Assets
65.9M
↑ 113325.13%
Total Liabilities
86.4M
↑ 125664.19%
Q2 FY23Q/Q Change
Total Assets
57.3M
↓ 13.1%
Total Liabilities
84.6M
↓ 2.11%
Q3 FY23Q/Q Change
Total Assets
42.3M
↓ 26.13%
Total Liabilities
74.3M
↓ 12.15%
Q4 FY23Q/Q Change
Total Assets
44.1M
↑ 4.31%
Total Liabilities
73.8M
↓ 0.67%
FY19Y/Y Change
Operating Cash Flow
-16.1M
-
Investing Cash Flow
-2.0M
-
Financing Cash Flow
12.5M
-
FY20Y/Y Change
Operating Cash Flow
-129.0K
↓ 99.2%
Investing Cash Flow
-1.1M
↓ 46.09%
Financing Cash Flow
6.5M
↓ 48.15%
FY21Y/Y Change
Operating Cash Flow
-40.6M
↑ 31372.87%
Investing Cash Flow
-2.0M
↑ 89.39%
Financing Cash Flow
120.6M
↑ 1767.45%
FY22Y/Y Change
Operating Cash Flow
-81.4M
↑ 100.49%
Investing Cash Flow
-1.6M
↓ 21.75%
Financing Cash Flow
-900.0K
↓ 100.75%
Q3 FY22Q/Q Change
Operating Cash Flow
-15.9M
↓ 43.76%
Investing Cash Flow
-160.0K
↓ 70.53%
Financing Cash Flow
2.0M
↓ 173.78%
Q4 FY22Q/Q Change
Operating Cash Flow
-7.4M
↓ 53.55%
Investing Cash Flow
-11.0K
↓ 93.12%
Financing Cash Flow
7.4M
↑ 273.8%
Q1 FY23Q/Q Change
Operating Cash Flow
-9.4M
↑ 26.97%
Investing Cash Flow
-162.0K
↑ 1372.73%
Financing Cash Flow
22.9M
↑ 210.73%
Q2 FY23Q/Q Change
Operating Cash Flow
-7.4M
↓ 21.24%
Investing Cash Flow
-11.0K
↓ 93.21%
Financing Cash Flow
7.4M
↓ 67.82%
Q3 FY23Q/Q Change
Operating Cash Flow
-5.2M
↓ 29.65%
Investing Cash Flow
-11.0K
↑ 0.0%
Financing Cash Flow
-4.4M
↓ 159.34%

Technicals Summary

Sell

Neutral

Buy

Owlet Inc is currently in a neutral trading position according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Owlet Inc
Owlet Inc
-10.96%
-1.73%
-17.26%
-59.92%
-58.97%
Solventum Corp
Solventum Corp
-10.52%
-10.52%
-10.52%
-10.52%
-10.52%
Veeva Systems Inc.
Veeva Systems Inc.
-14.44%
4.71%
12.48%
-29.78%
42.98%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
-3.5%
34.49%
7.28%
42.09%
42.09%
Healthequity Inc
Healthequity Inc
-0.55%
10.19%
46.83%
3.55%
8.89%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Owlet Inc
Owlet Inc
NA
NA
NA
0.0
-9.01
-0.35
NA
-4.27
Solventum Corp
Solventum Corp
NA
NA
NA
0.0
0.12
0.08
NA
NA
Veeva Systems Inc.
Veeva Systems Inc.
62.08
62.08
1.35
4.76
0.13
0.05
NA
28.8
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
27.94
27.94
20.11
4.3
0.19
0.06
0.0
15.67
Healthequity Inc
Healthequity Inc
123.75
123.75
2.29
2.19
0.03
0.03
NA
23.63
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Owlet Inc
Owlet Inc
Buy
$35.7M
-58.97%
NA
-60.92%
Solventum Corp
Solventum Corp
NA
$11.7B
-10.52%
NA
16.42%
Veeva Systems Inc.
Veeva Systems Inc.
Buy
$32.4B
42.98%
62.08
22.24%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
Buy
$38.8B
42.09%
27.94
8.02%
Healthequity Inc
Healthequity Inc
Buy
$6.8B
8.89%
123.75
5.57%

Institutional Holdings

  • ECLIPSE VENTURES, LLC

    22.70%

  • Pelion, Inc.

    3.63%

  • Vanguard Group Inc

    2.58%

  • Cresset Asset Management, LLC

    2.07%

  • BlackRock Inc

    0.70%

  • Dynamic Advisor Solutions LLC

    0.50%

Corporate Announcements

  • Owlet Inc Earnings

    Owlet Inc’s price-to-earnings ratio stands at None

    Read More

Company Information

Organization
Owlet Inc
Employees
76
CEO
Mr. Kurt Workman
Industry
Financial

Discover More

FAQs